Impact of Folic Acid Fortification in the United States: Markedly Diminished High Maternal Serum Alpha-Fetoprotein Values
- 1 March 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 103 (3) , 474-479
- https://doi.org/10.1097/01.aog.0000114984.82549.99
Abstract
Folic acid fortification of breads and grains was implemented in the United States in 1998 in an attempt to reduce the incidence of neural tube defects. Outcome data from birth registries have shown a 20% drop-less than originally predicted. In this study, we ascertain if the impact of folic acid fortification is better seen at the time of midtrimester prenatal diagnosis by looking at incidence of high maternal serum alpha-fetoprotein (MSAFP) values. Data regarding MSAFP levels in 61,119 patients undergoing maternal serum screening at a large commercial laboratory were categorized by multiples of the median (MoM). The data were compared between 2 groups: before mandatory supplementation in the United States in 1997 and after mandatory supplementation in 2000. High MSAFP values were further categorized as high (2.75-4.00 MoM) or very high (more than 4.00 MoM). Data were analyzed by chi(2) analysis. Comparative data showed a 32% decrease of patients with MoM greater than 2.75 + (2.5% -1.7%). Further categorizations revealed similar decreases. The introduction of folic acid fortification has produced a profound decrease in the number of high MSAFP values, reflective of a decreased incidence of neural tube defects. Our results help to validate the decision to fortify food with folic acid, which represents a highly successful public health policy for primary prevention of birth defects. II-2Keywords
This publication has 21 references indexed in Scilit:
- Standardization of Methods Reduces Variability: Explanation for Historical Discrepancies in Biochemical ScreeningGenetic Testing, 2003
- Maternal Weight Correction for α-Fetoprotein: Mathematical Truncations RevisitedGenetic Testing, 2002
- The Unnecessary Epidemic of Folic Acid-Preventable Spina Bifida and AnencephalyPediatrics, 2000
- Prevention of Neural-Tube Defects with Folic Acid in ChinaNew England Journal of Medicine, 1999
- Second-trimester maternal serum marker screening: Maternal serum α-fetoprotein, β-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcomeAmerican Journal of Obstetrics and Gynecology, 1999
- Variability of Adjustments to Indices in Determining Patient Risk in Biochemical ScreeningFetal Diagnosis and Therapy, 1999
- The surveillance of birth defects: the usefulness of the revised US standard birth certificate.American Journal of Public Health, 1996
- The sensitivity of ultrasound and serum alpha‐fetoprotein in population‐based antenatal screening for neural tube defects, South Australia 1986–1991BJOG: An International Journal of Obstetrics and Gynaecology, 1995
- Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin SupplementationNew England Journal of Medicine, 1992
- Prevention of neural tube defects: Results of the Medical Research Council Vitamin StudyPublished by Elsevier ,1991